Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis
Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Some efforts have been made to bioconjugate the MOG p...
Saved in:
Main Authors: | Mehrdad Gholamzad (Author), Hussein Baharlooi (Author), Mehdi Shafiee Ardestani (Author), Zeinab Seyedkhan (Author), Maryam Azimi (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methylene Blue Treatment Enhances Mitochondrial Function and Locomotor Activity in a C57BL/6 Mouse Model of Multiple Sclerosis
by: Mohammad Mehdi Ommati, et al.
Published: (2020) -
Stable Transfection of pEGFP-N1-MOG Plasmid to Utilize in Multiple Sclerosis Gene Therapy
by: Mohammad Hassan Karimfar, et al.
Published: (2015) -
Protection and Immune Responses Elicited by rSAG1-PLGA Nanoparticles in C57BL/6 Against Toxoplasma gondii
by: Mojgan Allahyari, et al.
Published: (2021) -
Effect of Crossing C57BL/6 and FVB Mouse Strains on Basal Cytokine Expression
by: Agata Szade, et al.
Published: (2015) -
Evaluation of apamin effects on myelination process in C57BL/6 mice model of multiple sclerosis
by: Maedeh Mohammadi-Rad, et al.
Published: (2019)